"You decide and we provide."
Cart 0

BRIEF-Oncomed's Phase 2 trial of Tarextumab in small cell lung cancer does not meet endpoints




reutersCOMPANYNEWS companyNews

* Oncomed's Phase 2 trial of Tarextumab in small cell lung cancer does not meet endpoints




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published